Auro Laboratories Ltd
Auro Laboratories Ltd Share Price Today: Live Updates & Key Insights
Get insights on Auro Laboratories Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Auro Laboratories Ltd Share Price Chart
AUROLABS at 05 Mar 2026 04:25 PM Pharmaceuticals
290.00 +1.70(+0.59%)
Lowest Today 285.00
Highest Today 294.90
Today's Open 286.00
Prev. Close 288.30
52 Week High 317.00
52 Week Low 159.00
Auro Laboratories Ltd Fundamentals
Traded Volume: 662
Market Cap(Cr): 181
Avg Traded Price 290.31
1 Year return 34.51%
Upper Circuit 294.9
Lower Circuit 285
P/E TTM 0.00
P/B Ratio 4.182
Traded Value(Cr) 1.92
EPS TTM NaN
Book value/Share 68.940
Dividend Yield 1Y 0.00%
Auro Laboratories Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Auro Laboratories Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Auro Laboratories Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W 0.00%
1M 0.00%
3M 0.00%
1Y +34.51%
YTD 0.00%
Auro Laboratories Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Auro Laboratories Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday N/A
Day Before Yesterday N/A
1W Avg N/A
1M Avg N/A
3M Avg N/A
Auro Laboratories Ltd Technical Details
Auro Laboratories Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 284
Support 2 280
Support 3 276
Pivot Point : 288
Resistance 1 292
Resistance 2 296
Resistance 3 300
Auro Laboratories Ltd Corporate Actions
Auro Laboratories Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Auro Laboratories Ltd’s capital allocation strategies.
All
Dividends
No Dividend has been declared by AUROLABS
Bonus
No Bonus has been declared by AUROLABS
Splits
No Split has been declared by AUROLABS
Others
Rights No Rights has been declared by AUROLABS
Auro Laboratories Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Auro Laboratories Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Auro Laboratories Ltd's relative performance and valuation against major competitors.
Stock Name Ambalal Sarabhai Enterprises Ltd ₹25.30 (+1.40%) M. Cap (Cr) 1.94 1 Yr Return (%) -29.70% P/E (TTM) 17.57 PB Ratio 1.28
Stock Name Oxygenta Pharmaceutical Ltd ₹50.35 (+0.70%) M. Cap (Cr) 1.86 1 Yr Return (%) -30.04% P/E (TTM) -10.33 PB Ratio -4.48
Stock Name Aptus Pharma Ltd ₹266.45 (+1.99%) M. Cap (Cr) 1.83 1 Yr Return (%) NaN% P/E (TTM) 58.97 PB Ratio 8.42
Stock Name Auro Laboratories Ltd ₹290.00 (+0.59%) M. Cap (Cr) 1.81 1 Yr Return (%) +34.51% P/E (TTM) 61.14 PB Ratio 3.97
Stock Name Brooks Laboratories Ltd ₹61.73 (-0.11%) M. Cap (Cr) 1.82 1 Yr Return (%) -40.67% P/E (TTM) 8.42 PB Ratio 1.57
Stock Name Quest Laboratories Ltd ₹110.20 (+0.18%) M. Cap (Cr) 1.81 1 Yr Return (%) -11.06% P/E (TTM) 13.31 PB Ratio 1.92
Stock Name Astonea Labs Ltd ₹155.00 (-2.21%) M. Cap (Cr) 1.63 1 Yr Return (%) NaN% P/E (TTM) 30.45 PB Ratio 3.05
Auro Laboratories Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Auro Laboratories Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2025 5.75 Mar 2024 18.81 Mar 2023 3.28 Mar 2022 -6.59 Mar 2021 5.80
PARTICULARS Investing Activities Mar 2025 -24.45 Mar 2024 -38.67 Mar 2023 -5.08 Mar 2022 -5.34 Mar 2021 3.51
PARTICULARS Financing Activities Mar 2025 17.69 Mar 2024 19.09 Mar 2023 -8.18 Mar 2022 9.79 Mar 2021 -0.46
PARTICULARS Net Cash Flow Mar 2025 -1.02 Mar 2024 -0.77 Mar 2023 -9.98 Mar 2022 -2.14 Mar 2021 8.85
Auro Laboratories Ltd Shareholding Pattern
This shows the ownership breakdown of Auro Laboratories Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter N/A%
Public N/A%
Other Institutions N/A%
FII N/A%
Mutual Funds N/A%
About Auro Laboratories Ltd
Auro Laboratories Limited, founded in 1992, has been manufacturing and providing generic Active Pharmaceutical Ingredients (API). Currently, the Company is specializing in producing Anti Diabetics like Metformin HCL. It is the first-line treatment for type 2 diabetes. The Company is headquartered in Mumbai and it has manufacturing facility at Palghar in Maharashtra. The facility has all the required certifications from Indian authorities and European registration organizationSince inception, the Company focused on providing quality pharmaceuticals while maintaining high manufacturing standards. Company presently has 1800 MTPA of Metformin HCL manufacturing capacity, with projects underway to expand the capacity to 3600 MTPA.The Company's primary focus was on Anti-Diabetic Drugs, which estimated to be one of the fastest growing therapeutic segments. Currently, it manufacture Metformin Hydrochloride and Glibenclamide and are on the anvil of introducing others within this segment. Additionally, it also undertake Toll/Custom Manufacturing for API's and Intermediates on contract basis. The manufacturing facility operates are per cGMP norms and has an installed capacity in excess of 500 Tonnes per annum.Auro laboratories has made its presence felt in international markets with a bulk of it production being exported to South East Asia, Middle East and several European Countries. Some of the countries the company exports to are Egypt, Germany, Malaysia, Singapore, South Africa, Brazil, Spain and United Kingdom.The Company received ISO 9001:2000 and WHO - cGMPs certification. It also received CERTIFICATE OF SUITABILITY (COS) from the European Directorate of Quality Medicine (EDQM) in September 2006.The Company has completed the Projects for capacity expansion of Metformin HCL from 1800 MTA to 3600 MTA and other products in 2025.
Chairman / Executive Director / M D / Promoter
Sharat Deorah
Registered office K-56 MIDC Indl Area, Tarapur Boisar, Thane, Maharashtra, 401506
FAX :91-22-66635456
Background
Incorporation Year 1989
Face Value ₹10.00
Market Lot 1
FAQs on Auro Laboratories Ltd
How to buy Auro Laboratories Ltd shares on NSE?
To buy Auro Laboratories Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the Auro Laboratories Ltd share price today?
The Auro Laboratories Ltd share price on NSE is ₹290.00 today.
What is the market cap of Auro Laboratories Ltd on NSE?
The company has a market capitalization of ₹180.74.
What is the PE & PB ratio of Auro Laboratories Ltd?
PE is N/A and PB is 4.182.
What is the 52 Week High and Low of Auro Laboratories Ltd shares?
Auro Laboratories Ltd stock price high: ₹317 Auro Laboratories Ltd stock price low: ₹159.